C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: The IMMIDIET Project

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 3, 2008, Pages 436-443

  Arcari, A ^a   Zito, F ^a   Di Castelnuovo, A ^a   De Curtis, A ^a   Dirckx, C ^b   Arnout, J ^b   Cappuccio, F P ^c   Van Dongen, M C J M ^d   De Lorgeril, M ^e   Krogh, V ^f   Siani, A ^g   Donati, M B ^a   De Gaetano, G ^a   Iacoviello, Licia ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e Lab Stress Cardiovasculaire P   (France)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g CNR   (Italy)

Author keywords

C reactive protein; Coronary heart disease; Metabolic syndrome; Obesity; Sex

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BELGIUM; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; EUROPE; FATALITY; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY ANALYSIS; SEX DIFFERENCE; UNITED KINGDOM; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CORONARY DISEASE; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REFERENCE VALUES; RISK;

EID: 39549121457     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02851.x     Document Type: Article

References (37)

1. Volanakis JE. Human C-reactive protein: Expression, structure, and function. Mol Immunol 2001; 38: 189-97.
2. Sun H, Koike T, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B, Kitajima S, Morimoto M, Watanabe T, Asada Y, Chen YE, Fan J. C-reactive protein in atherosclerotic lesions: Its origin and pathophysiological significance. Am J Pathol 2005; 167: 1139-48.
3. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England J Med, 1997; 336: 973-9.
4. Saleh N, Svane B, Hansson LO, Jensen J, Nilsson T, Danielsson O, Tornvall P. Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value. Clin Chem 2005; 51: 2124-30.
5. Pepys MB. CRP or not CRP? That is the question. Arterioscler Thromb Vasc Biol 2005; 25: 1091-4.
6. Jan N. CRP -marker or maker of cardiovascular disease? Arterioscler Thromb Vasc Biol 2005; 25: 1527-8.
7. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England J Med 2004; 350: 1387-97.
8. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events New England J Med 2002; 347: 1557-65.
9. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002; 22: 1668-73.
10. Schillaci G, Pirro M. C-reactive protein in hypertension: Clinical significance and predictive value. Nutr. Met Card Dis 2006; 16: 500-8.
11. Koenig W, Sund M, Fröhlich M, Fischer H-G, Löwel H, Döring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999; 99: 237-42.
12. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction. Aterioscler Thromb Vasc Biol 1999; 19: 972-8.
13. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001; 25: 1407-15.
14. Woodward M, Rumley A, Lowe GD, Tunstall-Pedoe H. C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 2003; 122: 135-41.
15. Thorand B, Baumert J, Doring A, Herder C, Kolb H, Rathmann W, Giani G, Koenig W; KORA Group. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis. 2006; 184: 216-24.
16. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-57.
17. Iacoviello L, Arnout J, Buntinx F, Cappuccio FP, Dagnelie PC, de Lorgeril M, Dirckx C, Donati MB, Krogh V, Siani A, on behalf of the European Collaborative Group of the IMMIDIET Project. Dietary habit profile in European Communities with different risk of myocardial infarction: The impact of migration as a model of gene-environment interaction-the IMMIDIET study. Nutr Metab Cardiovasc Dis 2001; 11 (Suppl.): 122-6.
18. Russo P, Lauria F, Loguercio M, Barba G, Arnout J, Cappuccio FP, de Lorgeril M, Donati MB, Iacoviello L, Krogh V, van Dongen M, Siani A; European Collaborative Group of the IMMIDIET Project. -344C/T variant in the promoter of the aldosterone synthase gene (CYP11B2) is associated with metabolic syndrome in men. Am J Hypertens 2007; 20: 218-22.
19. di Castelnuovo A, Quacquaruccio G, Arnout J, Cappuccio FP, de Lorgeril M, Dirckx C, Donati MB, Krogh V, Siani A, van Dongen MC, Zito F, de Gaetano G, Iacoviello L; European Collaborative Group of IMMIDIET Project. Cardiovascular risk factors and global risk of fatal cardiovascular disease are positively correlated between partners of 802 married couples from different European countries. Report from the IMMIDIET project. Thromb Haemost 2007; 98: 648-55.
20. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling: Results from a population-based study. JAMA 1993; 270: 354-9.
21. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: Recommendations of the European Society of Hypertension. BMJ 2001; 322: 531-6.
22. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults -the evidence report. National Institutes of Health. Obes Res 1998; 6(Suppl 2): 51S-209S.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
24. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, de Backer G, de Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 2003; 24: 987-1003.
25. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-62.
26. Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Formann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF Jr, Smith S Jr, Stone NJ, Taubert KA. Am Heart Association Expert Panel on Population and Prevention Science. Am Heart Association guide for improving cardiovascular health at the community level: A statement for public health practitioners, healthcare providers, and health policy makers from the Am Heart Association Expert Panel on Population and Prevention Science. Circulation 2003; 107: 645-51.
27. Yarnell J, McCrum E, Rumley A, Patterson C, Salomaa V, Lowe G, Evans A. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: The MONICA Optional Haemostasis Study. Eur Heart J 2005; 26: 332-42.
28. Hutchinson WL, Koenig W, Frohlich M, Sund M, Lowe GDO, Pepys MB. Immunoradiometric assay of circulating C-reactive protein: Age-related values in the adult general population. Clin Chem 2000; 46: 934-8.
29. McConnell JP, Branum EL, Ballman KV, Lagerstedt SA, Katzmann JA, Jaffe AS. Gender differences in C-reactive protein concentrations - confirmation with two sensitive methods. Clin Chem Lab Med 2002; 40: 56-9.
30. Pieroni L, Bastard JP, Piton A, Khalil L, Hainque B, Jardel C. Interpretation of circulating C-reactive protein levels in adults: Body mass index and gender are a must. Diabetes Metab 2003; 29(2 Pt 1): 133-8.
31. Ford ES, Giles WH, Myers GL, Rifai N, Ridker PM, Mannino DM. C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem 2003; 49: 1353-7.
32. Ledue TB, Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: Implications for cardiovascular disease risk assessment. Clin Chem 2003; 49: 1258-71.
33. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, Guralnik JM, Longo DL. The origins of age-related proinflammatory state. Blood 2005; 105: 2294-9.
34. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: A systematic review. Arch Intern Med 2007; 167: 31-9.
35. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined MS, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50years and older. Diabetes 2003; 52: 1210-4.
36. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110: 380-5.
37. Bo S, Gentile L, Ciccone G, Baldi C, Benini L, Dusio F, Lucia C, Forastiere G, Nuti C, Cassader M, Pagano GF. The metabolic syndrome and high C-reactive protein: Prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev 2005; 21: 515-24.